NeuBase Therapeutics Inc (NAS:NBSE)
$ 0.378 -0.012499 (-3.2%) Market Cap: 1.42 Mil Enterprise Value: -5.82 Mil PE Ratio: 0 PB Ratio: 0.15 GF Score: 21/100

NeuBase Therapeutics Inc Tribe Public's Presentation and Q&A Webinar Event Transcript

Oct 28, 2020 / 03:30PM GMT
Release Date Price: $167.4 (-2.90%)
John Heerdink
Jr, Tribe Public, LLC - Moderator

Presentation and Q&A Webinar Event
Oct 28, 2020 / 03:30PM GMT

=====================
Corporate Participants
=====================
* Dietrich Stephan
NeuBase Therapeutics, Inc. - CEO and Founder

=====================
Conference Call Participants
=====================
* John Heerdink, Jr
Tribe Public, LLC - Moderator

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot